The tide of share increase and repurchase of listed companies is coming.
According to the preliminary statistics of the reporter of securities times · e company, on March 8, a total of 21 companies in Shanghai Stock Market issued announcements related to share increase and repurchase, including 20 on the main board and 1 on the science and innovation board.
Specifically, one company newly disclosed the share repurchase plan, 12 disclosed the announcement of the progress of share repurchase, 3 disclosed the progress of share increase, 3 newly disclosed the plan of share increase, and 2 companies promised to continue to repurchase within 3 days; Involving Haier Smart Home Co.Ltd(600690) , Zhejiang Chint Electrics Co.Ltd(601877) , 360 Security Technology Inc(601360) and other large and medium-sized companies. Among them, Haier Smart Home Co.Ltd(600690) disclosed the plan to increase its holdings. It has increased its holdings by 145 million yuan today and will continue to increase its holdings by 200350 million yuan in the next six months.
Although only one sci-tech innovation board company released good news that night; However, from January 1 to March 4 this year, eight companies on the science and innovation board have announced share repurchase plans, and another four companies have announced plans to increase the holdings of controlling shareholders, actual controllers or directors, supervisors and senior executives.
According to the reporter’s observation, as for the share repurchase plan, the time for Kechuang company to formulate the repurchase plan is mainly concentrated in February and March; Generally, it shows the following characteristics: first, the distribution of industries is diverse, including 3 biomedical industries, 2 high-end equipment manufacturing, 1 environmental protection industry, 1 information technology industry and 1 software industry. Second, the repurchase amount is small. Except that Cansino Biologics Inc(688185) repurchase amount is not less than 150 million yuan, the amount promised by other companies for repurchase is not more than 100 million yuan. The upper limit of share repurchase proportion of enterprises with more than 60% shall not exceed 1%. Third, the purpose of repurchase is to implement employee stock ownership or equity incentive, and there was a large decline before the announcement of repurchase plan. The repurchased shares of 8 companies are used for equity incentive, and the share prices of relevant companies have shown a downward trend since this year. Among them, five companies fell by more than 10%, and Qingdao Haier Biomedical Co.Ltd(688139) also implemented share repurchase and actual controller increase plans.
Insiders told the reporter of the securities times · e company that the reasons for the repurchase of relevant companies are, on the one hand, to boost market confidence and reverse the decline of stock prices; On the other hand, it is to determine the ticket source for the subsequent implementation of equity incentive and reduce the incentive cost.
In addition to share repurchases, four Sci-tech Innovation Board companies announced plans to increase their holdings of relevant personnel in the same period. Qingdao Haier Biomedical Co.Ltd(688139) adopts both repurchase and holdings increase tools. From the perspective of the increase subject, except that the increase subject of Beijing Sun-Novo Pharmaceutical Research Co.Ltd(688621) is only senior managers, the other three companies have controlling shareholders or actual controllers to participate in the increase. In terms of the amount of increased holdings, the commitments of each company vary greatly Qingdao Haier Biomedical Co.Ltd(688139) increase in shareholding is the largest, no less than 100 million yuan Suzhou Zelgen Biopharmaceuticals Co.Ltd(688266) increased their holdings by about 20 million yuan, while Beijing Sun-Novo Pharmaceutical Research Co.Ltd(688621) and Beijing Sinohytec Co.Ltd(688339) promised to increase their holdings by about 10 million yuan.
